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Background: Pancreaticoduodenectomy is an increasingly common procedure performed for both benign and
malignant disease. There are conflicting data regarding the safety of pancreatic resection in older patients.
Potentially modifiable perioperative risk factors to improve outcomes in older patients have yet to be determined.
Methods: The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP)
database for 2008 to 2009 was used for this retrospective analysis. Patients undergoing pancreaticoduodenectomy
were identified and divided into those above and below the age of 65. Preoperative risk factors and postoperative
morbidity and mortality were evaluated.
Results: Among 2,045 patients included in this analysis, 994 patients were >65 years (48.6%) while 1,051 were (less
than or equal to) 65 years (51.4%). Thirty-day mortality was higher in the older age group compared to the younger
age group 3.6% vs. 1.9% respectively, P = 0.017, odds ratio 1.94. Older patients had a higher incidence of
unplanned intubation, ventilator support >48 h and septic shock compared with younger patients. On multivariate
logistic regression, after adjusting for other 30-day postoperative occurrences (significant at the P <0.1 level) only
septic shock was independently associated with a higher odds of mortality, unplanned intubation, and ventilator
support >48 h in older patients compared with younger patients.
Conclusions: This report from a population-based database is the first to highlight postoperative sepsis as an
independent risk factor for mortality and morbidity in older patients undergoing pancreatic resection. Careful
perioperative management addressing this issue is essential for patients over the age of 65.Background
Pancreatic cancer is the fourth leading cause of cancer-
related death in the United States with peak incidence be-
tween the ages of 60 and 80 years [1].
Pancreaticoduodenectomy or the Whipple procedure is a
potentially curative treatment for selected pancreatic and
periampullary cancers. Evolution of surgical techniques and
improvements in postoperative care have contributed sub-
stantially to its rising popularity [2]. Over the past three de-
cades, mortality rates following pancreaticoduodenectomy
for benign and malignant disease have dropped to less than* Correspondence: wfaraj@hotmail.com
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reproduction in any medium, provided the or2% in high-volume centers and morbidity rates to around
30% [3]. Despite advances in adjuvant therapy, the five-year
survival rate following pancreaticoduodenectomy for pan-
creatic cancer remains low at 15 to 25% [4].
As the general population is aging, a larger segment of
the population will be expected to present with conditions
requiring the Whipple procedure, thus posing a challenge
for surgeons and health care institutions. In the absence of
a uniform cutoff age, identifying older patients at higher
risk is cumbersome. Delineating the relative contribution of
patient baseline risk factors, operative course and postoper-
ative care to final patient outcomes in older patients is more
difficult. While studies from small centers investigating this
question lack statistical power, high-volume center studies
are flawed by patient selection.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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more pressing clinical concern, with increasingly longer life
expectancy. Seventy-five percent of patients with pancreatic
cancer are older than 60 years [5]. Currently, age alone is
not a contraindication to pancreatic resection [6].
The aim of this study is to compare postoperative
outcomes between older (>65 years) and young patients
(≤65 years) undergoing pancreaticoduodenectomy, and
to identify risk factors that contribute to the observed
differences.
Methods
This was a retrospective cohort study using data from the
American College of Surgeons National Surgical Quality
Improvement Program (ACS NSQIP) database. Details of
the ACS NSQIP (www.acsnsqip.org) have been recently de-
scribed [7]. The ACS NSQIP is a validated outcomes regis-
try designed to provide feedback to member hospitals on
30-day risk-adjusted surgical mortality and morbidity [8,9].
The database includes de-identified data on perioperative
variables and 30-day postoperative outcomes for adult pa-
tients undergoing major surgery in participating nonvet-
erans’ administration hospitals. Transplant and trauma
cases are excluded, specifically patients who are admitted to
the hospital with acute trauma and have surgery for that
trauma; any operation done after the patient has been
discharged from the trauma stay is included. Trained surgi-
cal clinical reviewers collect patient data upon admission
from the medical chart, operative log, anesthesia record, in-
terviews with the surgical attending, and telephone inter-
views with the patient [8]. Data quality is ensured through
comprehensive training of the nurse reviewers, an inter-
rater reliability audit of participating sites, regular confer-
ence calls, and an annual meeting [10].
For this study, the available ACS NSQIP participant use
files of the years 2008 (271,368 patients from 211 sites) and
2009 (336,190 patients from 237 sites) were retrieved for
major surgeries performed at participating ACS NSQIP
medical centers. We identified all Whipple cases using the
Current Procedural Terminology (CPT) code: 48150. A
total of 2,045 patients were identified and included in this
study. In accordance with the American University of
Beirut’s guidelines (which follow the US Code of Federal
Regulations for the Protection of Human Subjects), institu-
tional review board approval was not needed or sought for
our analysis because data were collected as part of a quality
assurance activity.
Risk factors
We divided patients into two groups according to age:
more and less than 65 years. The cutoff age of 65 was
based on the World Health Organization (WHO) classi-
fication for older people. For each patient, data were col-
lected for demographics, preoperative medical history,surgical settings, total operative time, and intraoperative
use of packed red blood cells (pRBC) transfusions.
Outcomes
Evaluated postoperative outcomes were 30-day mortality
and morbidity including: [1] wound (deep incisional surgical
site infection, organ or space surgical site infection, or
wound dehiscence); [2] respiratory (pneumonia, unplanned
intubation, or ventilator support >48 h); [3] cardiac (myocar-
dial infarction or cardiac arrest requiring cardiopulmonary
resuscitation); [4] cerebrovascular accident; [5] renal (acute
renal failure or progressive renal insufficiency; [6] systemic
sepsis (sepsis or septic shock); [7] venous thromboembolism
(VTE) (deep venous thrombosis or pulmonary embolism);
[8] major bleeding requiring >4 units of pRBC within 72
hours; and [9] unplanned return to the operating room
(Table 1).
Statistical analysis
Descriptive statistics are presented as means ± standard
deviation (SD), medians (interquartile range (IQR)), or per-
centages. Risk factors and outcomes were compared
between the two age groups (young vs. older) using the
chi-squared test for categorical variables and the independ-
ent samples t-test for continuous variables. The primary
study outcome measure was the incidence of mortality in
the older group compared with the young group. The sec-
ondary study outcome measure was the incidence of any
of the nine morbidities in the older group compared with
the young group.
To further scrutinize the association between age and
postoperative outcomes, we constructed multivariate logis-
tic regression models, where any significant association be-
tween age and 30-day mortality or morbidity was adjusted
for the occurrence of other 30-day postoperative morbid-
ities significant at the P <0.1 level on bivariate analysis. Ob-
serving modification of the effect estimates (odds ratios
(OR) and 95% confidence intervals (CI)) allowed for the
identification of the independent association between age
and the postoperative outcome, irrespective of the occur-
rence of other outcomes.
We also constructed multivariate logistic regression
models to identify the modifying effect of risk factors on
the estimate of any independent association between
age and outcomes. Risk factors were selected if they
were different between young and older patients at the
P <0.1 level. Through adjusting for each risk factor, we
were able to determine if it explains the observed asso-
ciation between age and outcome. All P values were
two-sided with the level of significance set at <0.05.
Results
Data from 2,045 patients were included in this analysis.
Their mean age was 64.1 ± 12.3 years (range: 17 to 90
Table 1 Incidence of 30-day postoperative outcomes in young and older patients undergoing the Whipple procedure
Outcome Young Older P value OR (95% CI)a
n = 1051 n= 994
MORTALITY 20 (1.9) 36 (3.6) 0.017 1.94 (1.11-3.37)
MORBIDITY
Wound 154 (14.7) 149 (15.0) 0.830 1.03 (0.81-1.31)
Deep incisional SSI 27 (2.6) 29 (2.9) 0.629 1.14 (0.67-1.94)
Organ/space incisional SSI 122 (11.6) 110 (11.1) 0.700 0.95 (0.72-1.25)
Wound dehiscence 17 (1.6) 24 (2.4) 0.199 1.51 (0.80-2.82)
Respiratory 99 (9.4) 124 (12.5) 0.027 1.37 (1.04-1.81)
Pneumonia 53 (5.0) 65 (6.5) 0.147 1.32 (0.91-1.91)
Unplanned intubation 48 (4.6) 69 (6.9) 0.021 1.56 (1.07-2.28)
Ventilator support >48 h 58 (5.5) 77 (7.7) 0.043 1.44 (1.01-2.05)
Cardiac 13 (1.2) 22 (2.2) 0.089 1.81 (0.91-3.61)
Myocardial infarction 3 (0.3) 9 (0.9) 0.067 3.19 (0.86-11.82)
Cardiac arrest necessitating CPR 10 (1.0) 16 (1.6) 0.184 1.70 (0.77-3.77)
Renal 21 (2.0) 25 (2.5) 0.431 1.27 (0.70-2.28)
Acute renal failure 11 (1.0) 8 (0.8) 0.569 0.77 (0.31-1.92)
Progressive renal insufficiency 14 (1.3) 17 (1.7) 0.484 1.29 (0.63-2.63)
Venous thromboembolism 30 (2.9) 38 (3.8) 0.222 1.35 (0.83-2.20)
Deep vein thrombosis 23 (2.2) 23 (2.3) 0.848 1.06 (0.59-1.90)
Pulmonary embolism 11 (1.0) 15 (1.5) 0.351 1.45 (0.66-3.17)
Systemic sepsis 156 (14.8) 159 (16.0) 0.470 1.09 (0.86-1.39)
Sepsis 130 (12.4) 102 (10.3) 0.133 0.81 (0.62-1.07)
Septic shock 33 (3.1) 61 (6.1) 0.001 2.03 (1.31-3.11)
Cerebrovascular accident 2 (0.2) 2 (0.2) 0.955 1.06 (0.15-7.52)
Major bleedingb 19 (1.8) 14 (1.4) 0.474 0.78 (0.39-1.56)
Return to operating room 91 (8.7) 82 (8.2) 0.740 0.95 (0.69-1.30)
Data presented as n (%).
aOdds of outcome in patients >65 years compared with ≤65 years (referent group).
bRequiring >4 units of packed red blood cells within first 72 h postoperatively.
OR odds ratio, CI confidence interval, SSI surgical site infection, CPR cardiopulmonary resuscitation.
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were >65 years (48.6%, older group) while 1,051 were
≤65 years (51.4%, young group). Table 2 summarizes the
top 10 most common diagnoses in patients undergoing
the Whipple procedure from both age groups.Risk factors
Older patients undergoing the Whipple procedure were
more likely to be at a higher American Society of Anesthesi-
ologists (ASA) class and nonindependent in functional sta-
tus compared with young patients (Table 3). They were also
more likely to have a history of diabetes, hypertension, per-
ipheral vascular disease, transient ischemic attacks, percu-
taneous coronary intervention, cardiac surgery, and dyspnea
at rest or moderate exertion; yet less likely to be obese.
Older patients also had a higher prevalence of chronicobstructive pulmonary disease; although they were less likely
to be current smokers, within one year of surgery. Both pre-
operative anemia and intraoperative pRBC transfusions were
more common in older compared with young patients.Postoperative outcomes
Mortality rate was found to be higher in the older age
group (3.6% vs. 1.9% young, P = 0.017, OR 1.94 (95% CI
1.11 to 3.37). Older patients had a higher incidence of un-
planned intubation, ventilator support >48 h and septic
shock compared with younger patients. However, on
multivariate logistic regression analysis and after adjusting
for other 30-day postoperative occurrence (significant at
the P <0.1 level) age was only independently associated
with a higher odds of septic shock, with the latter associ-
ation explaining the higher odds of mortality, unplanned
Table 2 Top 10 most common diagnosis in young and
older patients undergoing the Whipple procedure
Young (n = 1051) n (%)
Malignant neoplasm of head of pancreas 304 (28.9)
Malignant neoplasm of pancreas part unspecified 108 (10.3)
Chronic pancreatitis 73 (6.9)
Malignant neoplasm of ampulla of Vater 57 (5.4)
Malignant neoplasm of duodenum 56 (5.3)
Malignant neoplasm of pancreas 53 (5.0)
Benign neoplasm of pancreas except islets of Langerhans 45 (4.3)
Malignant neoplasm of other specified sites of pancreas 37 (3.5)
Unspecified disease of pancreas 27 (2.6)
Malignant neoplasm of extrahepatic bile ducts 24 (2.3)
Older (n = 994) n (%)
Malignant neoplasm of head of pancreas 338 (34.0)
Malignant neoplasm of pancreas part unspecified 119 (12.0)
Malignant neoplasm of ampulla of Vater 92 (9.3)
Malignant neoplasm of pancreas 65 (6.5)
Malignant neoplasm of duodenum 48 (4.8)
Benign neoplasm of pancreas except islets of Langerhans 43 (4.3)
Malignant neoplasm of other specified sites of pancreas 35 (3.5)
Malignant neoplasm of extrahepatic bile ducts 25 (2.5)
Malignant neoplasm of pancreatic duct 19 (1.9)
Unspecified disease of pancreas 15 (1.5)
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pared with younger patients (Table 4).
The median duration to the incidence of septic shock
in the older patient group was 8 days (IQR: 4 to 12 days,
min: 1 day, max: 29 days) which was similar to the youn-
ger patient group (median: 8 days, IQR: 3.5 to 13 days,
min: same day, max: 28 days). After adjusting for all risk
factors that had a different prevalence between younger
and older patients (significant at the P <0.1 level), the
odds ratio for septic shock in older compared with youn-
ger patients remained essentially unchanged; indicating
that none of the evaluated risk factors could explain the
observed association between age and septic shock
(Table 5).Discussion
In this large multicenter study, we have found that patients
over the age of 65 undergoing pancreaticoduodenectomy
have increased postoperative mortality rates compared to
younger patients largely due to an increased risk of septic
shock. Despite the fact that older patients had a higher
prevalence of pre- and intraoperative interoperative risk fac-
tors, these could not explain the observed increase in the
incidence of septic shock in this cohort. Our findings haveimportant clinical implications for management of the older
patient undergoing pancreatic resection.
We abandoned the classical look at the chronological
age as an absolute cutoff splitting patients into safe and
danger zones [11,12]. We used age 65 as proposed by
WHO to look deeper into the inherent characteristics of
older patients [6]. This cutoff is closer to the mean age
in our analysis (64.1 years), providing us with the highest
statistical power to come to robust conclusions. We in-
cluded a comprehensive list of risk factors associated
with older age and studied their effect on postoperative
outcomes using multivariate analysis.
When looking at the indications for pancreatic resec-
tion, we found that malignant processes whether in older
or in young patients, account for the largest group of
performed procedures (Table 2). Tumors at the head of
the pancreas account for only 62.9% of cases, reflecting
the widening distribution of indications as well a rising
acquaintance by surgeons. Notably, chronic pancreatitis,
while being the third diagnosis in the young age group,
does not appear among the most common 10 diagnoses
in the older age group. This finding is likely to reflect a
persistent hesitance in performance of the Whipple pro-
cedure for benign conditions in older patients rather
than decreased incidence in this cohort. We have found
that patients over the age of 65 undergoing pancreatico-
duodenectomy have increased postoperative mortality rates
compared to younger patients largely due to an increased
risk of septic shock. In previous reports, the incidence of
postoperative septic shock had been overlooked. Postopera-
tive mortality was associated with the pathology of the
underlying resection specimen [13,14], intraoperative blood
loss [15], postoperative surgical complications [16,17], ad-
vanced ASA score, history of dyspnea [5], or preoperative
hypoalbuminemia [18].
Old age, defined as more than 65 years, is an
established risk factor for developing sepsis regardless
of other comorbidities [19]. Patients in this age category
also fare worse in terms of survival or late-term morbid-
ity following septic shock [20]. Several hypotheses
attempted to explain this association. Aging of the im-
mune system ‘immunosenescence’ attributes this obser-
vation to the decreased capacity of the immune system
to properly handle foreign microorganisms with ad-
vanced age [21,22]. Functional decline in innate as well
as adaptive immune systems have been described in ani-
mal models and human cell lines and correlated with
decreased immune function [23-27]. Beside failure of
development of adequate defensive response against for-
eign pathogens, aging is also associated with prolonged
release of inflammatory cytokines. Aged mice cells were
more affected by the levels of lipopolysaccharide (LPS)
and tumor necrosis factor (TNF) than younger cells
[28]. An exaggerated response to inflammatory markers
Table 3 Prevalence of risk factors in young and older
patients undergoing the Whipple procedure
Parameter Young Older P value
n = 1051 n = 994
Male 552 (52.5) 518 (52.1) 0.853
White race 812 (77.3) 834 (83.9) <0.001
Totally or partially dependent in
functional status
23 (2.2) 39 (3.9) 0.022
ASA classificationa <0.001
I or II 378 (36.0) 234 (23.5)
III 640 (60.9) 688 (69.2)
IV or V 33 (3.1) 72 (7.2)
BMI ≥30 kg/m2 303 (28.8) 210 (21.1) <0.001
Diabetic on oral agents or insulin 213 (20.3) 262 (26.4) 0.001
Alcohol intake in two weeks prior
(>2 drinks/day)
46 (4.4) 28 (2.8) 0.059
Hypertension requiring
medication
412 (39.2) 655 (65.9) <0.001
Dyspnea on moderate exertion/
at rest
72 (6.9) 107 (10.8) 0.002
Congestive heart failure in
30 days prior
2 (0.2) 5 (0.5) 0.226
Angina in 30 days prior 3 (0.3) 7 (0.7) 0.175
Myocardial infarction in
6 months prior
4 (0.4) 3 (0.3) 0.760
Previous percutaneous coronary
intervention
50 (4.8) 98 (9.9) <0.001
Previous cardiac surgery 30 (2.9) 93 (9.4) <0.001
History of peripheral vascular
diseaseb
9 (0.9) 21 (2.1) 0.018
Current smoker (within 1 year) 348 (33.1) 140 (14.1) <0.001
History of severe COPD 42 (4.0) 77 (7.7) <0.001
History of transient ischemic
attack
8 (0.8) 42 (4.2) <0.001
History of CVA without neuro
deficit
18 (1.7) 26 (2.6) 0.160
History of CVA with neuro deficit 12 (1.1) 21 (2.1) 0.082
Anemiac 433 (41.2) 511 (51.4) <0.001
Bleeding disorder 24 (2.3) 36 (3.6) 0.073
Weight loss >10% in 6 months
prior
217 (20.6) 190 (19.1) 0.386
Disseminated cancer 32 (3.0) 26 (2.6) 0.559
Tumor involving central nervous
system
2 (0.2) 0 (0.0) 0.169
Chemotherapy in 30 days prior 28 (2.7) 15 (1.5) 0.069
Radiotherapy in 90 days prior 37 (3.5) 31 (3.1) 0.613
Ascites in 30 days prior 3 (0.3) 6 (0.6) 0.277
Esophageal varices in 6 months
prior
1 (0.1) 0 (0.0) 0.331
Currently on dialysis 3 (0.3) 5 (0.5) 0.431
Table 3 Prevalence of risk factors in young and older
patients undergoing the Whipple procedure (Continued)
Prior operation within 30 days 16 (1.5) 24 (2.4) 0.145
Infected surgical wound class 15 (1.4) 19 (1.9) 0.392
Total operation time, min
(mean ± SD)




0 738 (70.2) 620 (62.4)
1 or 2 193 (18.4) 234 (23.5)
≥3 120 (11.4) 140 (14.1)
Data presented as n (%) unless otherwise indicated.
aAmerican Society of Anesthesiologists (ASA) scores: I, healthy patient; II, mild
systemic disease but no functional limitations; III, severe systemic disease with
definite functional limitations; IV, severe systemic disease that is a constant
threat to life; and V, moribund patient unlikely to survive 24 hours with or
without operation.
bRequiring revascularization, angioplasty, or amputation.
cHematocrit concentration <36% in women and <39% in men. BMI, body
mass index.
COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident,
SD standard deviation, pRBC packed red blood cell.
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levels of albumin and total cholesterol, common in
older patients, are other surrogate markers for suscepti-
bility to increased sepsis and mortality [31-33]. The syn-
drome of frailty affecting older people has recently
received special attention. Underlying sarcopenia is a
generalized catabolic state with a general decline of
physiological body reserves. A frailty index has been de-
veloped and found to predict postoperative outcomes in
older patients [34].
The strong correlation between septic shock and mortal-
ity draws attention to the contribution of postoperative care
in optimizing outcomes in older patients. The fact that age
by itself is a risk factor for the development of septic shock
mandates a rapid response to early sign of infection. Ag-
gressive intervention is of utmost importance to prevent
rapid deterioration of older patients. These data call for fur-
ther investigation of antibiotic prophylaxis for older patients
undergoing pancreatic resection.
Limitations of this study include lack of information re-
garding antibiotic treatment in this cohort. Since the ACS
NSQIP does not include data on the use of antimicrobial
agents, so we could not evaluate the association between
the use of certain drugs and the incidence of septic shock.
Another potential limitation of this study was that we were
unable to control for hospital effects owing to the absence
of hospital identifiers in our data. There may have been
variability in hospital quality or variability in surgical strat-
egy, which may have potentially confounded the association
between risk factors and outcome. Finally, the possibility of
omitted variable bias is always present in observational
studies.
Table 4 Adjustment of significant associations between age and 30-day postoperative outcomes for the incidence of
other postoperative outcomes
Factor 30-day postoperative outcome in older vs. young patients
Mortality Unplanned intubation Ventilator support >48 h Septic shock
UNADJUSTED 1.94 (1.11-3.37) 1.56 (1.07-2.28) 1.44 (1.01-2.05) 2.03 (1.31-3.11)
ADJUSTED FOR
Myocardial infarction 1.89 (1.08-3.29) 1.51 (1.03-2.21) 1.42 (0.99-2.01) 1.97 (1.28-3.05)
Unplanned intubation 1.63 (0.89-2.96) 1.21 (0.79-1.85) 1.84 (1.11-3.07)
Ventilator support >48 h 1.77 (1.01-3.12) 1.39 (0.88-2.19) 1.92 (1.16-3.19)
Septic shock 1.56 (0.88-2.80) 1.16 (0.74-1.82) 1.08 (0.71-1.64)
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postoperative complications following pancreatic resection.
It sheds light on the increased risk of sepsis in older patients.
It also emphasizes the importance of postoperative care as
equal to the patient baseline risk profile and intraoperative
course in ensuring safety of outcomes. Interestingly, the
contribution of septic shock was masked in previous single







Totally or partially dependent in functional status Refere
ASA classification Refere
BMI ≥30 kg/m2 Refere
Diabetic on oral agents or insulin Refere
Alcohol intake in two weeks prior (>2 drinks/day) Refere
Hypertension requiring medication Refere
Dyspnea on moderate exertion/at rest Refere
Previous percutaneous coronary intervention Refere
Previous cardiac surgery Refere
History of peripheral vascular disease Refere
Current smoker (within 1 year) Refere
History of severe COPD Refere
History of transient ischemic attack Refere
History of CVA with neuro deficit Refere
Anemia Refere
Bleeding disorder Refere
Chemotherapy in 30 days prior Refere
Total operation time Refere
Intraoperative pRBC transfusion Refere
OR odds ratio, CI confidence interval, ASA American Society of Anesthesiologists, BM
cerebrovascular accident, pRBC packed red blood cell.in postoperative care are major contributors to the mortality
and morbidity of patients’ post-Whipple procedure. Further
research should be focused on improving prophylactic mea-
sures to prevent and early identify sepsis among older
patients.
We suggest the following protocol for those patients:
in the preoperative setting, a multidisciplinary approach
is performed for each patient.eptic shock upon adjustment for risk factors
Septic shock
g Older P value
5% CI) OR (95% CI)
nt 2.03 (1.31-3.11) 0.001
nt 2.00 (1.30-3.09) 0.002
nt 1.94 (1.26-3.00) 0.003
nt 1.77 (1.14-2.75) 0.010
nt 2.06 (1.34-3.19) 0.001
nt 2.01 (1.30-3.10) 0.002
nt 2.04 (1.32-3.14) 0.001
nt 1.84 (1.18-2.89) 0.007
nt 1.91 (1.23-2.95) 0.004
nt 1.94 (1.25-2.99) 0.003
nt 1.90 (1.22-2.94) 0.004
nt 2.00 (1.30-3.10) 0.002
nt 2.09 (1.34-3.26) 0.001
nt 1.94 (1.25-2.99) 0.003
nt 1.99 (1.28-3.07) 0.002
nt 2.01 (1.31-3.10) 0.002
nt 1.95 (1.26-3.00) 0.003
nt 1.95 (1.26-3.02) 0.003
nt 2.05 (1.33-3.16) 0.001
nt 2.12 (1.37-3.28) 0.001
nt 1.88 (0.76-1.87) 0.005
I body mass index, COPD chronic obstructive pulmonary disease, CVA
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is performed. Presurgical biliary drainage is performed for
patients presenting with severe jaundice (total bilirubin
more than 5 mg/dl, normal range is 0 to 1.2). Older patients
are admitted 24 to 48 hours prior to surgery. Preoperative
subcutaneous anticoagulation according to weight is given
the night before surgery. All patients will be on intravenous
antibiotics using broad-spectrum coverage for multi organ-
isms including Gram-positive, Gram-negative, anaerobes
and fungal infections. Patients are educated for using the
incentive spirometer 24 to 48 hours prior to surgery.
Intraoperative monitoring with repetitive blood testing is
routinely performed. Blood transfusion is only given when
the hemoglobin is less than 8 g/dl (normal range is 12 to
18 g/dl).
Most of our patients are transferred to a regular ward
postoperatively, only critical patients are transferred to
the intensive care unit.
Postoperative antibiotics are maintained for 3 to 4 days,
anticoagulation therapy is maintained until the time of
discharge.
Conclusions
In conclusion, age is not a contraindication to pancreatic
resection, however, this study highlights the fact that
older patients have increased morbidity and mortality re-
lated to increased risk of postoperative sepsis. With this
information, protocols for older patients to minimize
these increased risks should be developed.
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